When did Amphastar Pharmaceuticals report Q4 2024 earnings?

Amphastar Pharmaceuticals (AMPH) reported Q4 2024 earnings on February 27, 2025 after market close.

What were Amphastar Pharmaceuticals's Q4 2024 revenue and EPS?

Amphastar Pharmaceuticals reported revenue of $186.5M and eps of $0.92 for Q4 2024.

Did Amphastar Pharmaceuticals beat estimates in Q4 2024?

Revenue missed the consensus estimate of $188.8M by $2.3M. EPS missed the consensus estimate of $1.01 by $0.09.

Where can I find Amphastar Pharmaceuticals's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001297184-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.

Amphastar Pharmaceuticals AMPH Q4 2024 Annual earnings

Reported February 27, 2025 · After market close

Revenue$186.5MMiss by $2.3M

EPS$0.92Miss by $0.09

Revenue estimate$188.8M

EPS estimate$1.01

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$179.9M

EPS estimate$0.66

Financials

Q4 2024

Income statement

See full

Revenue$186.5M+4.7%

Gross profit$86.6M-9.9%

Operating income$45.1M-16.4%

Net income$38.0M+5.0%

EPS (diluted)$0.74+7.2%

Balance sheet

See full

Cash & equivalents$151.6M+5.1%

Total debt$651.0M+4.3%

Total assets$1.6B+4.3%

Cash flow

See full

Operating cash flow$29.0M+21.6%

CapEx$12.4M+31.4%

Free cash flow$16.6M+15.2%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.79B-39.7%

Enterprise value$2.28B-33.6%

P/E11.2×-10.4×

P/S2.4×-2.2×

Profitability

See full

Gross margin51.1%-3.4pp

Operating margin28.1%-2.5pp

Net margin21.8%+0.4pp

FCF margin23.5%+1.0pp

Returns & leverage

See full

Current ratio3.1×+0.9×

Segments

By geography

See full

US$175.1M-0.1%

FR$9.2M+1,913%

CN$2.2M-7.2%

Versus estimates

Revenue

Q1 2026$171.2MMiss by $2.3M Q4 2025$183.1MMiss by $5.7M Q3 2025$191.8MBeat by $1.4M Q2 2025$174.4MMiss by $2.7M Q1 2025$170.5MMiss by $2.5M

Q4 2024$186.5MMiss by $2.3M

Diluted EPS

Q1 2026$0.42Miss by $0.28 Q4 2025$0.73Miss by $0.17 Q3 2025$0.93Beat by $0.16 Q2 2025$0.85Beat by $0.14 Q1 2025$0.74Beat by $0.08

Q4 2024$0.92Miss by $0.09

Ask the moment Amphastar Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Amphastar Pharmaceuticals report Q4 2024 earnings?: Amphastar Pharmaceuticals (AMPH) reported Q4 2024 earnings on February 27, 2025 after market close.
What were Amphastar Pharmaceuticals's Q4 2024 revenue and EPS?: Amphastar Pharmaceuticals reported revenue of $186.5M and eps of $0.92 for Q4 2024.
Did Amphastar Pharmaceuticals beat estimates in Q4 2024?: Revenue missed the consensus estimate of $188.8M by $2.3M. EPS missed the consensus estimate of $1.01 by $0.09.
Where can I find Amphastar Pharmaceuticals's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001297184-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.